Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Analyst Forecast

$3.65

$0.28 (-7.13%)
Last update: 04:00 PM EST
Day's range
$3.57
Day's range
$4.05

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
10/21/2024 Robert W. Baird Joel Beatty $32.00 $16.07   99.13%
04/30/2024 RBC Capital Brian Abrahams $30.00 $16.00   87.5%
04/29/2024 Stifel Nicolaus Paul Matteis $29.00 $16.00   81.25%

Contineum Therapeutics, Inc. Class A Common Stock FAQ's

Contineum Therapeutics, Inc. Class A Common Stock has been rated by research analysts at Robert W. Baird, RBC Capital, Stifel Nicolaus in the past 90 days.